BioNeutra Global : Notice

BIONEUTRA GLOBAL CORPORATION

NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS

NOTICE IS HEREBY GIVEN that the annual general and special meeting (the "Meeting") of the holders (the "Shareholders") of common shares ("Shares") of BioNeutra Global Corporation (the "Corporation") is scheduled to be held in an in-person and virtual format (see link below) with the in-person format to be held at the Terminal City Club, 837 West Hastings Street, Vancouver, British Columbia, V6C 1B6 on Friday, July 8,

2022 at 2:00 p.m. (Vancouver time) for the following purposes:

1. to receive the annual audited financial statements of the Corporation for the financial year ended December 31, 2021, together with the auditors' report thereon;
2. to fix the size of the board of directors at five (5) members;
3. to elect the board of directors to serve until the next annual meeting of the Shareholders or until their successors are duly elected or appointed;
4. to appoint Kenway Mack Slusarchuk Stewart LLP, Chartered Professional Accountants, as auditors and to authorize the board of directors to fix the auditors' remuneration;
5. to consider and, if thought advisable, to pass, with or without amendment, an ordinary resolution to approve a stock option plan attached as Schedule C to this Information Circular whereby a maximum of ten (10%) percent of the Corporation's issued and outstanding Shares will be reserved for issuance from time to time; and
6. to transact such other business as may properly be brought before the Meeting, or any adjournment or adjournments thereof.

Specific details of the matters proposed to be put before the Meeting are set forth in the Information Circular, which Information Circular forms a part of this notice.

Each person who is a Shareholder of record at the close of business on June 1, 2022 (the "Record Date"), will be entitled to notice of, and to attend and vote at, the Meeting provided that, to the extent a Shareholder as of the Record Date transfers the ownership of any Shares after such date and the transferee of those Shares establishes that the transferee owns the Shares and demands, not later than 10 days before the Meeting, to be included in the list of Shareholders eligible to vote at the Meeting, such transferee will be entitled to vote those Shares at the Meeting.

Edmonton, Alberta	By Order of the Board Of Directors
June 1, 2022	(Signed) Jianhua Zhu
	Chief Executive Officer

YOUR VOTE IS IMPORTANT. Shareholders who are unable to attend the Meeting in person can attend the meeting athttps://us05web.zoom.us/j/7682394822?pwd=a0VRbE0zY3RRZUM3Zjh6aTlQWTVBZz09(Zoom

Meeting ID: 768 239 4822; Passcode: Bioneutra) BUT WILL NOT BE ABLE TO VOTE AT THE MEETING. THEREFORE,we strongly urge and ask all shareholders who are attending the Meeting virtually to vote their shares well in advance of the meeting date by COMPLETING AND SIGNING THE ACCOMPANYING FORM OF PROXY to be received by no later than 48 hours (excluding Saturdays, Sundays and holidays) before the time set for the holding of the Meeting or any adjournment thereof. All Shareholders who are unable to attend the meeting are requested to COMPLETE AND SIGN THE ACCOMPANYING FORM OF PROXY and return it to Computershare Trust Company of Canada, Proxy Dept., 100 University Avenue, 8th Floor, Toronto, Ontario, M5J 2Y1. Alternatively, you may vote by telephone at 1-866-732-VOTE(8683) (toll free within North America) or 1-312-588-4290(outside North America), or by internet using the 15 digit control number located at the bottom of your proxy at www.investorvote.com. All instructions are listed in the proxy form. Shareholders are cautioned that the use of mail to transmit proxies is at each Shareholder's risk.